Collegium Pharmaceutical Inc
NASDAQ:COLL
Income Statement
Earnings Waterfall
Collegium Pharmaceutical Inc
Revenue
|
566.8m
USD
|
Cost of Revenue
|
-240.6m
USD
|
Gross Profit
|
326.2m
USD
|
Operating Expenses
|
-150.7m
USD
|
Operating Income
|
175.5m
USD
|
Other Expenses
|
-127.3m
USD
|
Net Income
|
48.2m
USD
|
Income Statement
Collegium Pharmaceutical Inc
Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
+325%
|
4
+129%
|
8
+92%
|
19
+155%
|
29
+49%
|
90
+216%
|
160
+77%
|
218
+36%
|
280
+29%
|
291
+4%
|
293
+1%
|
296
+1%
|
297
+0%
|
299
+1%
|
302
+1%
|
308
+2%
|
310
+1%
|
321
+4%
|
326
+1%
|
326
0%
|
277
-15%
|
273
-1%
|
314
+15%
|
362
+15%
|
464
+28%
|
525
+13%
|
537
+2%
|
547
+2%
|
567
+4%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(3)
|
(45)
|
(92)
|
(137)
|
(166)
|
(172)
|
(174)
|
(174)
|
(194)
|
(182)
|
(163)
|
(147)
|
(130)
|
(125)
|
(128)
|
(130)
|
(126)
|
(129)
|
(168)
|
(203)
|
(250)
|
(282)
|
(272)
|
(261)
|
(241)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
+275%
|
3
+120%
|
6
+91%
|
17
+175%
|
26
+50%
|
45
+73%
|
68
+52%
|
81
+19%
|
115
+42%
|
120
+4%
|
120
+0%
|
122
+2%
|
103
-15%
|
117
+13%
|
139
+19%
|
161
+16%
|
180
+12%
|
197
+9%
|
198
+1%
|
196
-1%
|
151
-23%
|
144
-5%
|
146
+2%
|
158
+9%
|
214
+35%
|
243
+13%
|
265
+9%
|
286
+8%
|
326
+14%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||
Operating Expenses |
(14)
|
(15)
|
(18)
|
(27)
|
(39)
|
(59)
|
(76)
|
(96)
|
(105)
|
(105)
|
(103)
|
(100)
|
(110)
|
(120)
|
(130)
|
(135)
|
(137)
|
(135)
|
(132)
|
(127)
|
(125)
|
(126)
|
(122)
|
(124)
|
(124)
|
(126)
|
(130)
|
(125)
|
(125)
|
(129)
|
(135)
|
(145)
|
(158)
|
(158)
|
(156)
|
(151)
|
|
Selling, General & Administrative |
(3)
|
(6)
|
(11)
|
(19)
|
(28)
|
(46)
|
(63)
|
(81)
|
(92)
|
(94)
|
(93)
|
(91)
|
(102)
|
(111)
|
(121)
|
(127)
|
(128)
|
(125)
|
(122)
|
(116)
|
(115)
|
(116)
|
(112)
|
(114)
|
(114)
|
(115)
|
(119)
|
(116)
|
(115)
|
(122)
|
(130)
|
(141)
|
(158)
|
(158)
|
(156)
|
(151)
|
|
Research & Development |
(11)
|
(9)
|
(6)
|
(8)
|
(11)
|
(13)
|
(13)
|
(15)
|
(13)
|
(11)
|
(10)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(11)
|
(10)
|
(10)
|
(11)
|
(7)
|
(6)
|
(4)
|
0
|
0
|
0
|
0
|
|
Operating Income |
(14)
N/A
|
(15)
-4%
|
(18)
-19%
|
(27)
-54%
|
(39)
-45%
|
(59)
-51%
|
(76)
-29%
|
(94)
-24%
|
(102)
-8%
|
(99)
+3%
|
(86)
+13%
|
(74)
+14%
|
(66)
+11%
|
(52)
+21%
|
(49)
+4%
|
(21)
+58%
|
(18)
+15%
|
(15)
+13%
|
(10)
+32%
|
(24)
-128%
|
(9)
+63%
|
13
N/A
|
39
+203%
|
56
+45%
|
72
+29%
|
72
0%
|
67
-8%
|
25
-62%
|
18
-27%
|
17
-9%
|
23
+42%
|
69
+197%
|
86
+23%
|
106
+24%
|
130
+23%
|
175
+35%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
(5)
|
(11)
|
(16)
|
(18)
|
(13)
|
(7)
|
(1)
|
1
|
(4)
|
(12)
|
(21)
|
(29)
|
(30)
|
(27)
|
(24)
|
(21)
|
(21)
|
(34)
|
(47)
|
(62)
|
(75)
|
(75)
|
(72)
|
(68)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
(32)
|
(35)
|
(36)
|
(36)
|
(41)
|
(37)
|
(37)
|
(32)
|
|
Pre-Tax Income |
(14)
N/A
|
(15)
-4%
|
(18)
-19%
|
(27)
-53%
|
(39)
-44%
|
(59)
-50%
|
(76)
-29%
|
(94)
-24%
|
(102)
-8%
|
(98)
+3%
|
(85)
+13%
|
(75)
+12%
|
(71)
+6%
|
(63)
+11%
|
(66)
-5%
|
(39)
+40%
|
(30)
+23%
|
(22)
+28%
|
(11)
+48%
|
(23)
-99%
|
(13)
+45%
|
1
N/A
|
18
+3 540%
|
28
+52%
|
43
+55%
|
45
+6%
|
43
-6%
|
(3)
N/A
|
(35)
-921%
|
(52)
-51%
|
(60)
-15%
|
(29)
+52%
|
(31)
-6%
|
(6)
+80%
|
21
N/A
|
76
+257%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
62
|
61
|
75
|
78
|
17
|
17
|
4
|
1
|
(5)
|
(12)
|
(28)
|
|
Income from Continuing Operations |
(14)
|
(15)
|
(18)
|
(27)
|
(39)
|
(59)
|
(76)
|
(94)
|
(102)
|
(98)
|
(85)
|
(75)
|
(71)
|
(63)
|
(66)
|
(39)
|
(30)
|
(22)
|
(11)
|
(23)
|
(13)
|
0
|
18
|
27
|
42
|
107
|
104
|
72
|
43
|
(35)
|
(43)
|
(25)
|
(29)
|
(11)
|
9
|
48
|
|
Net Income (Common) |
(13)
N/A
|
(9)
+33%
|
(11)
-23%
|
(20)
-89%
|
(36)
-81%
|
(59)
-64%
|
(76)
-29%
|
(94)
-24%
|
(102)
-8%
|
(98)
+3%
|
(85)
+13%
|
(75)
+12%
|
(71)
+6%
|
(63)
+11%
|
(66)
-5%
|
(39)
+40%
|
(30)
+23%
|
(22)
+28%
|
(11)
+48%
|
(23)
-99%
|
(13)
+45%
|
0
N/A
|
18
+5 800%
|
27
+51%
|
42
+57%
|
107
+154%
|
104
-3%
|
72
-31%
|
43
-40%
|
(35)
N/A
|
(43)
-21%
|
(25)
+42%
|
(29)
-17%
|
(11)
+62%
|
9
N/A
|
48
+435%
|
|
EPS (Diluted) |
-0.65
N/A
|
-0.7
-8%
|
-0.51
+27%
|
-1.48
-190%
|
-1.56
-5%
|
-2.52
-62%
|
-3.23
-28%
|
-3.88
-20%
|
-3.45
+11%
|
-3.34
+3%
|
-2.85
+15%
|
-2.47
+13%
|
-2.14
+13%
|
-1.89
+12%
|
-2.01
-6%
|
-1.19
+41%
|
-0.91
+24%
|
-0.65
+29%
|
-0.33
+49%
|
-0.68
-106%
|
-0.35
+49%
|
-0.01
+97%
|
0.49
N/A
|
0.76
+55%
|
1.02
+34%
|
2.58
+153%
|
2.85
+10%
|
1.74
-39%
|
1.26
-28%
|
-1.05
N/A
|
-1.23
-17%
|
-0.74
+40%
|
-0.86
-16%
|
-0.25
+71%
|
0.21
N/A
|
1.15
+448%
|